19.10.2017 Views

EMET_PRIZE_2017

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

RUTH ARNON (Wikimedia Commons)<br />

MICHAEL SELA (Wikimedia Commons)<br />

A spotlight on Israel’s<br />

two scientific pioneers<br />

• By JUDY SIEGEL-ITZKOVICH<br />

Prof. Michael Sela and Prof.<br />

Ruth Arnon – both world-renowned<br />

scientists – have<br />

worked together for six decades,<br />

she originally as his student at the<br />

Weizmann Institute of Science and<br />

then as his research partner and<br />

friend.<br />

Today, he at 93 and she at 84<br />

years of age, both continue to<br />

work in their Weizmann labs – and<br />

they are together members of a<br />

eight-person Award Committee<br />

appointed by the prime minister<br />

and the A.M.N. Foundation for the<br />

Advancement of Science, Art and<br />

Culture responsible for a unique<br />

award.<br />

The <strong>EMET</strong> Prize is a $1 million<br />

annual prize given for excellence in<br />

academic and professional achievements<br />

by the A.M.N. Foundation.<br />

It was endowed in 1999 by the late<br />

Alberto Moscona Nisim, a Mexican<br />

friend of Israel who objected to the<br />

fact that, at that time, no Israeli scientists<br />

had received Nobel Prizes.<br />

“This was before Prof. Avraham<br />

Hershko and Prof. Aaron Ciechanover<br />

(along with US scientist<br />

Irwin Rose) received the 2004<br />

Nobel Prize for the discovery of<br />

ubiquitin-mediated protein degradation,”<br />

she pointed out.<br />

Sela is working on fighting cancer,<br />

while Arnon is busy both on an<br />

anti-cancer vaccine and developing<br />

a universal influenza vaccine<br />

that would not have to be injected<br />

every year.<br />

Together, however, along with<br />

the late Dvora Teitelbaum, they<br />

developed over many years the<br />

blockbuster drug to alleviate multiple<br />

sclerosis (MS) named Copaxone.<br />

Originally called COP-1, it<br />

was shown in their lab to efficiently<br />

suppress experimental autoimmune<br />

encephalomyelitis – an animal<br />

model of brain inflammation<br />

– and to be clinically beneficial<br />

in MS. It has since helped many<br />

hundreds of thousands of patients<br />

around the world by reducing the<br />

number and severity of neurological<br />

attacks.<br />

In MS, the body’s immune system<br />

plunders and damages the<br />

myelin sheath surrounding nerves<br />

in the brain and spinal cord that<br />

constitute the central nervous<br />

system. Acting like insulation on<br />

electrical wires, the myelin sheath<br />

facilitates the conduction of nerve<br />

signals along pathways. But when<br />

it is degraded, nerve signals are<br />

weakened or silenced, resulting in<br />

impaired functioning of systems<br />

that those nerves serve. “When<br />

we started the research, we didn’t<br />

6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!